On the evening of May 16, Ali Health released its 2018 financial year results announcement: the current year's revenue was 2.443 billion yuan, and the gross profit was 653 million yuan, up 414.2% and 248.7% respectively. After eliminating the equity incentive fee, the profit reached 8 million, making it profit for the first time.
According to the results announcement, “The strong growth in revenue and gross profit was mainly due to the rapid growth of health product sales business and e-commerce platform service revenue during the year.â€
In the current year, Alibaba Health provided outsourcing and value-added services to the e-commerce platform service business. The total transaction volume of goods exceeded 30 billion yuan, and the sales revenue of health products and service revenue of e-commerce platform reached 2.149 billion yuan and 171 million yuan respectively.
As of March 31, 2018, Ali Health's various business data showed that nearly 23,000 practitioners, licensed pharmacists and dietitians who signed online medical consulting services with Ali Health had a total of nearly 23,000. The number of active users authorized to open the "My Health" service in mobile phone Taobao has reached 28 million. More than 7,500 companies have settled in the “code-safe†tracking system, in which the number of pharmaceutical manufacturers reached 2,865, which is more than 80% of the total number of pharmaceutical manufacturers in China.
According to the announcement, “Alibaba Health’s continuous improvement in profitability will help to invest heavily in medical artificial intelligence in the future.†Ali Health officially launched the medical AI brand “Doctor You†in July last year. Zhejiang, Shanghai Xinhua Hospital, Shanghai Ruijin Hospital and other medical institutions to cooperate. (Source: Titanium Media)
Electrocoagulation Instruments
Electrocoagulation Instruments,Laparoscopic Bipolar Forceps,Bipolar Forceps,Insulated Grasping Forceps
ZHEJIANG SHENDASIAO MEDICAL INSTRUMENT CO.,LTD. , https://www.sdsmedtools.com